Primara Health Sciences supplies pharmaceutical-grade peptide therapies and GLP-1 / GLP-2 compounds to verified B2B partners, pairing GMP manufacturing with the documentation, logistics, and support that serious distribution requires.
Primara exists to make advanced peptide therapies accessible to the clinics, pharmacies, and distributors who deliver them, without asking those partners to compromise on provenance or paperwork.
We treat testing, chain-of-custody, and lot-level documentation as core deliverables. Every compound we ship carries the evidence of how it was made and verified so the partners who build their businesses on our supply can do so with confidence.

Four principles shape every decision, from which compounds we carry to how we document them.
Every lot is manufactured to exact specification and verified against it: identity, potency, and purity confirmed before a single vial leaves the facility.
GMP manufactured globally with HPLC purity of ≥ 99%. Documentation, not marketing, is how we prove it.
Cold-chain logistics and portal-based ordering built so verified partners can move quickly without compromising standards.
We supply the product and the backend so our partners can focus on the clinicians, patients, and brands they serve.
Quality that can't be traced isn't quality. Here's what accompanies every order.
Produced under Good Manufacturing Practice conditions globally with documented process controls.
Identity, HPLC purity, and endotoxin results documented and available before dispatch.
Unique PHS-LOT / PHS-COA references tie every vial to its manufacturing and testing record.
Storage and handling conditions recorded from manufacture through delivery.